Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Brand Insights - Thought Leadership | Paid Program | MilliporeSigma

The State of Plastics Recycling in BioPharma

ByJacqueline Hollands, Global Manager, Product Recycling & Innovation at MilliporeSigma
August 28th 2023

Brand Insights - Thought Leadership | Paid Program

Key Challenges for Manufacturers and How MilliporeSigma is Leading Industry-Wide Change

Advertisement
Advertisement

Trending on PharmExec

1

Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing

2

FDA Approves Tecentriq for Stage III dMMR Colon Cancer

3

Viatris Acquires Pacira BioSciences for $1.65 Billion

4

The Unmet Needs That Will Define the Next Generation of GLP 1s: Q&A with Dr. Bo Liang

5

Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us